Novakivskyy V. PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION. Ukr. J. Nephrol. Dial. [Internet]. 2017Mar.3 [cited 2026Jun.26];0(1(53):26-1. Available from: https://ukrjnd.com.ua/index.php/journal/article/view/217